Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | CRHBP | P24387 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2208703 | 0.87 | ALDH1A1 (0.42) | ALDH1A1KDM4EL3MBTL1MAPTCYP1A2 | |
| SCHEMBL12700373 | 0.87 | CDK4 (0.32) | ALDH1A1KDM4EL3MBTL1MAPTCYP1A2 | |
| SCHEMBL12433936 | 0.85 | ALDH1A1 (0.43) | ALDH1A1KDM4EL3MBTL1MAPTCYP1A2 | |
| SCHEMBL26463284 | 0.84 | CYP1A2 (0.37) | ALDH1A1KDM4EL3MBTL1MAPTCYP1A2 | |
| SCHEMBL12700367 | 0.84 | KDM4E (0.33) | ALDH1A1KDM4EL3MBTL1MAPTCYP1A2 | |
| SCHEMBL9971798 | 0.83 | HPGD (0.38) | ALDH1A1KDM4EL3MBTL1MAPTCYP1A2 | |
| SCHEMBL13658706 | 0.82 | ALDH1A1 (0.40) | ALDH1A1KDM4EL3MBTL1MAPTCYP1A2 | |
| SCHEMBL9888959 | 0.81 | CRHBP (0.42) | ALDH1A1KDM4EL3MBTL1MAPTCYP1A2 | |
| SCHEMBL12433938 | 0.80 | HSD17B1 (0.35) | ALDH1A1KDM4EL3MBTL1MAPTCYP1A2 | |
| SCHEMBL12433944 | 0.80 | HSD17B1 (0.35) | ALDH1A1KDM4EL3MBTL1MAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10804469-B2 | Charge transport material, organic electroluminescent element, and illumination device, display device, or light-emitting device characterized by using said element | UDC IRELAND LIMITED (IE) | 2020-10-13 | — | — | US | disclosed |
| US-20150069332-A1 | CHARGE TRANSPORT MATERIAL, OGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE, DISPLAY DEVICE, OR LIGHT-EMITTING DEVICE CHARACTERIZED BY USING SAID ELEMENT | UDC IRELAND LIMITED (IE) | 2015-03-12 | — | — | US | disclosed |
| US-20150069332-A1 | CHARGE TRANSPORT MATERIAL, OGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE, DISPLAY DEVICE, OR LIGHT-EMITTING DEVICE CHARACTERIZED BY USING SAID ELEMENT | UDC IRELAND LIMITED (IE) | 2015-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10804469-B2 | Charge transport material, organic electroluminescent element, and illumination device, display device, or light-emitting device characterized by using said element | ITGAL, ITGA1, ITGB1 | ALDH1A1 1035/4885KDM4E 3242/4885L3MBTL1 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.